Correlation Between Curative Biotechnology and Moderna
Can any of the company-specific risk be diversified away by investing in both Curative Biotechnology and Moderna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Curative Biotechnology and Moderna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Curative Biotechnology and Moderna, you can compare the effects of market volatilities on Curative Biotechnology and Moderna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Curative Biotechnology with a short position of Moderna. Check out your portfolio center. Please also check ongoing floating volatility patterns of Curative Biotechnology and Moderna.
Diversification Opportunities for Curative Biotechnology and Moderna
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Curative and Moderna is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Curative Biotechnology and Moderna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moderna and Curative Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Curative Biotechnology are associated (or correlated) with Moderna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moderna has no effect on the direction of Curative Biotechnology i.e., Curative Biotechnology and Moderna go up and down completely randomly.
Pair Corralation between Curative Biotechnology and Moderna
Given the investment horizon of 90 days Curative Biotechnology is expected to generate 22.31 times more return on investment than Moderna. However, Curative Biotechnology is 22.31 times more volatile than Moderna. It trades about 0.08 of its potential returns per unit of risk. Moderna is currently generating about -0.07 per unit of risk. If you would invest 2.50 in Curative Biotechnology on November 9, 2024 and sell it today you would lose (1.25) from holding Curative Biotechnology or give up 50.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.74% |
| Values | Daily Returns |
Curative Biotechnology vs. Moderna
Performance |
| Timeline |
| Curative Biotechnology |
| Moderna |
Curative Biotechnology and Moderna Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Curative Biotechnology and Moderna
The main advantage of trading using opposite Curative Biotechnology and Moderna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Curative Biotechnology position performs unexpectedly, Moderna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moderna will offset losses from the drop in Moderna's long position.| Curative Biotechnology vs. Biotron Limited | Curative Biotechnology vs. biOasis Technologies | Curative Biotechnology vs. Covalon Technologies | Curative Biotechnology vs. Mosaic Immunoengineering |
| Moderna vs. CureVac NV | Moderna vs. Novavax | Moderna vs. Ocean Biomedical | Moderna vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |